The safety and efficacy of hybrid ablation for the treatment of atrial fibrillation: A meta-analysis
| العنوان: | The safety and efficacy of hybrid ablation for the treatment of atrial fibrillation: A meta-analysis |
|---|---|
| المؤلفون: | Xinchun Yang, Xiandong Yin, Xingpeng Liu, Xiaoqing Liu, Yun-Qiu Jiang, Shu-Nan He, Li-Jun Zeng, Yan-Jiang Wang, Liang Shi, Yuxing Wang, Zhi-Tao Zheng, Ying Tian |
| المصدر: | PLoS ONE PLoS ONE, Vol 13, Iss 1, p e0190170 (2018) |
| سنة النشر: | 2017 |
| مصطلحات موضوعية: | Cardiovascular Procedures, medicine.medical_treatment, lcsh:Medicine, 030204 cardiovascular system & hematology, law.invention, Cohort Studies, 0302 clinical medicine, Mathematical and Statistical Techniques, Randomized controlled trial, law, Atrial Fibrillation, Clinical endpoint, Medicine and Health Sciences, lcsh:Science, Multidisciplinary, Pharmaceutics, Atrial fibrillation, Research Assessment, Ablation, Research Design, Meta-analysis, Physical Sciences, Cardiology, Catheter Ablation, medicine.symptom, Open Heart Surgery, Arrhythmia, Statistics (Mathematics), Research Article, Biotechnology, medicine.medical_specialty, Catheters, Drug Administration, Systematic Reviews, Catheter ablation, Surgical and Invasive Medical Procedures, Research and Analysis Methods, 03 medical and health sciences, Drug Therapy, Internal medicine, medicine, Humans, Statistical Methods, Atrial tachycardia, business.industry, lcsh:R, Biology and Life Sciences, medicine.disease, 030228 respiratory system, lcsh:Q, Medical Devices and Equipment, business, Complication, Mathematics, Meta-Analysis |
| الوصف: | Introduction Hybrid ablation, an emerging therapy that combines surgical intervention and catheter ablation, has become a viable option for the treatment of persistent atrial fibrillation. In this analysis, we aimed to evaluate the safety and efficacy of hybrid ablation, as well as compare the outcomes of one-step and staged approaches. Methods We conducted a search in major online databases and selected the studies that met the inclusion criteria. The primary endpoint was defined as no episode of atrial fibrillation or atrial tachycardia lasting longer than 30 seconds without administration of antiarrhythmic drugs. Results Sixteen studies including 785 patients (paroxysmal atrial fibrillation, n = 83; persistent atrial fibrillation, n = 214; long-standing persistent atrial fibrillation, n = 488) were selected. Average history of atrial fibrillation was (5.0±1.6) years. The pooled proportion of patients who were arrhythmia-free at the primary endpoint was 73% (95% CI, 64%–81%, Cochran’s Q, P |
| تدمد: | 1932-6203 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d67dd3922047be585a1380b6e36bdd0f https://pubmed.ncbi.nlm.nih.gov/29298352 |
| Rights: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....d67dd3922047be585a1380b6e36bdd0f |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 19326203 |
|---|